These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

79 related items for PubMed ID: 7895527

  • 1. Leukemia-associated changes identified by quantitative flow cytometry: I. CD10 expression.
    Lavabre-Bertrand T, Janossy G, Ivory K, Peters R, Secker-Walker L, Porwit-MacDonald A.
    Cytometry; 1994 Dec 15; 18(4):209-17. PubMed ID: 7895527
    [Abstract] [Full Text] [Related]

  • 2. [Detection of minimal residual disease in B lineage acute lymphoblastic leukemia by 4-color flow cytometry].
    Liu YR, Wang H, Chang Y, Cheng YF, Fu JY, Zhang LP, Liu GL, Chen SS.
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jun 15; 26(6):327-31. PubMed ID: 16185473
    [Abstract] [Full Text] [Related]

  • 3. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
    Consolini R, Legitimo A, Rondelli R, Guguelmi C, Barisone E, Lippi A, Cantù-Rajnoldi A, Aricò M, Conter V, Cocito MG, Putti MC, Pession A, Masera G, Biondi A, Basso G.
    Haematologica; 1998 Nov 15; 83(11):967-73. PubMed ID: 9864914
    [Abstract] [Full Text] [Related]

  • 4. Flow cytometry in the differential diagnosis of lymphocyte-rich thymoma from precursor T-cell acute lymphoblastic leukemia/lymphoblastic lymphoma.
    Li S, Juco J, Mann KP, Holden JT.
    Am J Clin Pathol; 2004 Feb 15; 121(2):268-74. PubMed ID: 14983942
    [Abstract] [Full Text] [Related]

  • 5. Comparative phenotype mapping of normal vs. malignant pediatric B-lymphopoiesis unveils leukemia-associated aberrations.
    Dworzak MN, Fritsch G, Fleischer C, Printz D, Fröschl G, Buchinger P, Mann G, Gadner H.
    Exp Hematol; 1998 Apr 15; 26(4):305-13. PubMed ID: 9546313
    [Abstract] [Full Text] [Related]

  • 6. Immunophenotypic analysis of CD19+ precursors in normal human adult bone marrow: implications for minimal residual disease detection.
    Ciudad J, Orfao A, Vidriales B, Macedo A, Martínez A, González M, López-Berges MC, Valverde B, San Miguel JF.
    Haematologica; 1998 Dec 15; 83(12):1069-75. PubMed ID: 9949623
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection.
    DiGiuseppe JA, Fuller SG, Borowitz MJ.
    Cytometry B Clin Cytom; 2009 Mar 15; 76(2):150-5. PubMed ID: 18831072
    [Abstract] [Full Text] [Related]

  • 8. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
    Ling JY, Sun XF, Yan SL, He LR, Zhen ZJ, Xia Y.
    Ai Zheng; 2007 Apr 15; 26(4):418-22. PubMed ID: 17430665
    [Abstract] [Full Text] [Related]

  • 9. Quantitative immunocytofluorometry--new parameters for the definition of leukemia cells.
    Babusíková O, Glasová M, Stasáková J, Kusenda J, Koníková E.
    Neoplasma; 1997 Apr 15; 44(6):348-55. PubMed ID: 9605006
    [Abstract] [Full Text] [Related]

  • 10. Anti-CD10 immunoperoxidase staining of paraffin-embedded acute leukemias: comparison with flow cytometric immunophenotyping.
    Bavikatty NR, Ross CW, Finn WG, Schnitzer B, Singleton TP.
    Hum Pathol; 2000 Sep 15; 31(9):1051-4. PubMed ID: 11014570
    [Abstract] [Full Text] [Related]

  • 11. Shifts in expression of immunological cell markers in relapsed acute leukemia.
    Tomová A, Babusíková O.
    Neoplasma; 2001 Sep 15; 48(3):164-8. PubMed ID: 11583283
    [Abstract] [Full Text] [Related]

  • 12. Expression of CD10, CD19 and CD34 markers in bone marrow samples of children with precursor B-cell acute lymphoblastic leukemia in clinical and hematological remission.
    Cáp J, Babusíková O, Kaiserová E, Jamárik M.
    Neoplasma; 1998 Sep 15; 45(4):231-6. PubMed ID: 9890666
    [Abstract] [Full Text] [Related]

  • 13. Combined use of reverse transcriptase polymerase chain reaction and flow cytometry to study minimal residual disease in Philadelphia positive acute lymphoblastic leukemia.
    Muñoz L, López O, Martino R, Brunet S, Bellido M, Rubiol E, Sierra J, Nomdedéu JF.
    Haematologica; 2000 Jul 15; 85(7):704-10. PubMed ID: 10897122
    [Abstract] [Full Text] [Related]

  • 14. Leukemia-associated phenotypes: their characteristics and incidence in acute leukemia.
    Babusíková O, Glasová M, Koníková E, Kusenda J.
    Neoplasma; 1996 Jul 15; 43(6):367-72. PubMed ID: 8996560
    [Abstract] [Full Text] [Related]

  • 15. The usefulness of flow cytometric CD10 detection in the differential diagnosis of peripheral T-cell lymphomas.
    Stacchini A, Demurtas A, Aliberti S, Francia di Celle P, Godio L, Palestro G, Novero D.
    Am J Clin Pathol; 2007 Nov 15; 128(5):854-64. PubMed ID: 17951210
    [Abstract] [Full Text] [Related]

  • 16. Aberrant expression of B203.13 antigen in acute lymphoid leukemia of B-cell origin.
    Gobbi G, Mirandola P, Malinverno C, Sponzilli I, Carubbi C, Ricci F, Binazzi R, Basso G, Giuliani-Piccari G, Ramazzotti G, Pasquantonio G, Cocco L, Vitale M.
    Int J Oncol; 2008 Aug 15; 33(2):371-4. PubMed ID: 18636158
    [Abstract] [Full Text] [Related]

  • 17. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
    Rezaei A, Adib M, Mokarian F, Tebianian M, Nassiri R.
    Med Sci Monit; 2003 Aug 15; 9(8):CR359-62. PubMed ID: 12942032
    [Abstract] [Full Text] [Related]

  • 18. The analogy in cell immunophenotype and parameters of cell cycle of ectopic thymus, normal thymus, and some acute lymphoblastic leukemia of T-phenotype.
    Babusíková O, Tomová A.
    Neoplasma; 2002 Aug 15; 49(5):312-8. PubMed ID: 12458329
    [Abstract] [Full Text] [Related]

  • 19. Comparison of multiparameter flow cytometry with cluster analysis and immunohistochemistry for the detection of CD10 in diffuse large B-Cell lymphomas.
    Xu Y, McKenna RW, Kroft SH.
    Mod Pathol; 2002 Apr 15; 15(4):413-9. PubMed ID: 11950915
    [Abstract] [Full Text] [Related]

  • 20. The immunophenotypes of blast cells in B-cell precursor acute lymphoblastic leukemia: how different are they from their normal counterparts?
    Sędek Ł, Bulsa J, Sonsala A, Twardoch M, Wieczorek M, Malinowska I, Derwich K, Niedźwiecki M, Sobol-Milejska G, Kowalczyk JR, Mazur B, Szczepański T.
    Cytometry B Clin Cytom; 2014 Sep 15; 86(5):329-39. PubMed ID: 24845957
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.